Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: an ITC perspective
… of modulation of transporter expression and/or function in the … their impact on pharmacokinetics
(PKs), drug–drug interactions (… changes in pediatric patients may alter systemic and/or …
(PKs), drug–drug interactions (… changes in pediatric patients may alter systemic and/or …
Drug transporters in the kidney: perspectives on species differences, disease status, and molecular docking
W Zou, B Shi, T Zeng, Y Zhang, B Huang… - Frontiers in …, 2021 - frontiersin.org
… transporters could affect the pharmacokinetics of many drugs… substrates or inhibitors of the
drug transporters. Here, we review … potential substrates and/or inhibitors of transporters by the …
drug transporters. Here, we review … potential substrates and/or inhibitors of transporters by the …
Intestinal drug transporters in pathological states: An overview
M Drozdzik, I Czekawy, S Oswald, A Drozdzik - Pharmacological Reports, 2020 - Springer
… and Alzheimer disease) may affect drug transporter expression and … content may not only
affect pharmacokinetics of its drug … are derived from in vitro and/or animal studies, and should …
affect pharmacokinetics of its drug … are derived from in vitro and/or animal studies, and should …
Membrane carriers and transporters in kidney physiology and disease
M Drozdzik, M Drozdzik, S Oswald - Biomedicines, 2021 - mdpi.com
… uptake carriers and/or efflux transporters may lead to reduced drug … may mediate altered
drug pharmacokinetics, drug–drug … disease affects expression and function of drug carriers and …
drug pharmacokinetics, drug–drug … disease affects expression and function of drug carriers and …
Regulation of drug transport proteins—From mechanisms to clinical impact: A white paper on behalf of the international transporter consortium
… , 7 physiologically based pharmacokinetic (PBPK) modeling … carbamazepine with drug
transporter substrates can result in … Direct regulation of human drug transporters (mRNA and/or …
transporter substrates can result in … Direct regulation of human drug transporters (mRNA and/or …
Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment
F Stanke-Labesque, E Gautier-Veyret, S Chhun… - Pharmacology & …, 2020 - Elsevier
… condition shared by numerous chronic diseases. In addition, … drugs that affect DMETs are
well-known variables that can … exposure and/or pharmacokinetic parameters of the main drugs …
well-known variables that can … exposure and/or pharmacokinetic parameters of the main drugs …
Transporters in drug development: International transporter consortium update on emerging transporters of clinical importance
…, International Transporter Consortium - Clinical …, 2022 - Wiley Online Library
… Drugs can elicit folate deficiency by interfering with folate metabolism and/or transport (eg, …
affects celiprolol pharmacokinetics (PK) at the therapeutic dose. However, in vitro …
affects celiprolol pharmacokinetics (PK) at the therapeutic dose. However, in vitro …
Disease-induced modulation of drug transporters at the blood–brain barrier level
SB Al Rihani, LI Darakjian, M Deodhar, P Dow… - International Journal of …, 2021 - mdpi.com
… drugs may reach the CNS by passive diffusion or be subjected to putative influx and/or efflux
through BBB membrane transporters… transport of drugs impacting their pharmacokinetics [46]…
through BBB membrane transporters… transport of drugs impacting their pharmacokinetics [46]…
Impact of changes in free concentrations and drug-protein binding on drug dosing regimens in special populations and disease states
MN Celestin, FM Musteata - Journal of pharmaceutical sciences, 2021 - Elsevier
… the pharmacokinetic parameters affected by changes in drug … affinity to albumin can impact
free drug concentrations. Free … in an increased efficacy of the drug and/or increase the risk of …
free drug concentrations. Free … in an increased efficacy of the drug and/or increase the risk of …
Pharmacokinetics in children with chronic kidney disease
AM Schijvens, SN de Wildt, MF Schreuder - Pediatric Nephrology, 2020 - Springer
… P-gp-mediated drug transport might result in increased oral … -related low plasma albumin,
conformational change of the … , and/or drug metabolites competing with the acidic drugs for …
conformational change of the … , and/or drug metabolites competing with the acidic drugs for …